Article
Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines
1 Apr 2009
Abstract excerpt
The tumor-associated Tn antigen has been investigated extensively as a biomarker and therapeutic target. Cancer vaccines containing the Tn antigen as a single tumor antigen or as a component of a polyvalent vaccine have progressed into phase I and II clinical trials. One major focus of Tn-based vaccines is the treatment of prostate cancer patients. Although expression of the antigen on prostate tumors is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
